Cargando…
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition
SIMPLE SUMMARY: Estrogen receptors α (ERα) and β (ERβ) show distinct contributions to tumor initiation and progression. Given that ERβ mainly functions as a “tumor suppressor”, activation of ERβ using its specific agonist should be able to inhibit tumor progression. In this study, we show that a new...
Autores principales: | Banerjee, Ananya, Cai, Shurui, Xie, Guozhen, Li, Na, Bai, Xuetao, Lavudi, Kousalya, Wang, Kevin, Zhang, Xiaoli, Zhang, Junran, Patnaik, Srinivas, Backes, Floor J., Bennett, Chad, Wang, Qi-En |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105687/ https://www.ncbi.nlm.nih.gov/pubmed/35565440 http://dx.doi.org/10.3390/cancers14092311 |
Ejemplares similares
-
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression
por: Lavudi, Kousalya, et al.
Publicado: (2023) -
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition
por: Cai, Shurui, et al.
Publicado: (2022) -
A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs
por: Goud, Vaggu Raghavendra, et al.
Publicado: (2022) -
2-Dimensional in vitro culture assessment of ovarian cancer cell line using cost effective silver nanoparticles from Macrotyloma uniflorum seed extracts
por: Lavudi, Kousalya, et al.
Publicado: (2022) -
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
por: Lavudi, Kousalya, et al.
Publicado: (2023)